These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11009864)

  • 1. Program variation in treatment outcomes among women in residential drug treatment.
    Grella CE; Joshi V; Hser YI
    Eval Rev; 2000 Aug; 24(4):364-83. PubMed ID: 11009864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the tidal model of mental health recovery to plan primary health care for women in residential substance abuse recovery.
    Young BB
    Issues Ment Health Nurs; 2010 Sep; 31(9):569-75. PubMed ID: 20701419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of recent findings on substance abuse treatment for pregnant women.
    Howell EM; Heiser N; Harrington M
    J Subst Abuse Treat; 1999 Apr; 16(3):195-219. PubMed ID: 10194738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final thoughts on IMPACT: a federally funded, jail-based, drug-user-treatment program.
    Swartz JA; Lurigio AJ
    Subst Use Misuse; 1999 May; 34(6):887-906. PubMed ID: 10227116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women in residential drug treatment: differences by program type and pregnancy.
    Grella CE
    J Health Care Poor Underserved; 1999 May; 10(2):216-29. PubMed ID: 10224827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting.
    Grella CE
    J Psychoactive Drugs; 1996; 28(4):319-43. PubMed ID: 9017555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnant adolescents in chemical dependency treatment. Description and outcomes.
    Farrow JA; Watts DH; Krohn MA; Olson HC
    J Subst Abuse Treat; 1999 Mar; 16(2):157-61. PubMed ID: 10023614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of drug addicts in the health center].
    Poras JP
    Soins Psychiatr; 1993 Oct; (156):7-12. PubMed ID: 8115875
    [No Abstract]   [Full Text] [Related]  

  • 9. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of women-only and mixed-gender drug abuse treatment programs.
    Grella CE; Polinsky ML; Hser YI; Perry SM
    J Subst Abuse Treat; 1999; 17(1-2):37-44. PubMed ID: 10435251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenting training for women in residential substance abuse treatment. Results of a demonstration project.
    Camp JM; Finkelstein N
    J Subst Abuse Treat; 1997; 14(5):411-22. PubMed ID: 9437610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residential substance abuse treatment for pregnant and postpartum women and their children: treatment and policy implications.
    Clark HW
    Child Welfare; 2001; 80(2):179-98. PubMed ID: 11291900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse treatment for women: changes in the settings where women received treatment and types of services provided, 1987-1998.
    Grella CE; Greenwell L
    J Behav Health Serv Res; 2004; 31(4):367-83. PubMed ID: 15602139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse issues among women in domestic violence programs: findings from North Carolina.
    Martin SL; Moracco KE; Chang JC; Council CL; Dulli LS
    Violence Against Women; 2008 Sep; 14(9):985-97. PubMed ID: 18703771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's programs versus mixed-gender day treatment: results from a randomized study.
    Kaskutas LA; Zhang L; French MT; Witbrodt J
    Addiction; 2005 Jan; 100(1):60-9. PubMed ID: 15598193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community residential program policies, services, and treatment orientations influence patients' participation in treatment.
    Moos RH; King MJ; Burnett EB; Andrassy JM
    J Subst Abuse; 1997; 9():171-87. PubMed ID: 9494948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of program completion for women in residential substance abuse treatment.
    Knight DK; Logan SM; Simpson DD
    Am J Drug Alcohol Abuse; 2001 Feb; 27(1):1-18. PubMed ID: 11373028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttreatment outcomes for substance-abusing probationers mandated to residential treatment.
    Hiller ML; Knight K; Devereux J; Hathcoat M
    J Psychoactive Drugs; 1996; 28(3):291-6. PubMed ID: 8895113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of an outpatient program for women with substance use-related disorders on retention.
    Zilberman ML; Tavares H; Andrade AG; El-Guebaly N
    Subst Use Misuse; 2003 Dec; 38(14):2109-24. PubMed ID: 14677784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders.
    Godley MD; Godley SH; Dennis ML; Funk RR; Passetti LL
    Addiction; 2007 Jan; 102(1):81-93. PubMed ID: 17207126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.